SCHEMBL826159

SCHEMBL826159

CCCOCCOc1nc(N)nc2ccc(-c3ccc(NC(=O)OC)cc3)nc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
RARB P10826 1/20 0.36
MAPKAPK2 P49137 2/20 0.36
LMNA P02545 2/20 0.35
MAPK1 P28482 2/20 0.35
HIF1A Q16665 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 3/20 0.34
ALDH1A1 P00352 2/20 0.34
ROCK2 O75116 1/20 0.34
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
CCNB2 O95067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL826238 0.93 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DRARB
SCHEMBL826437 0.90 GHSR (0.41) PDE4APDE4BPDE4CPDE4DRARB
SCHEMBL823688 0.90 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DMAPKAPK2
SCHEMBL826453 0.89 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DMAPKAPK2
SCHEMBL823755 0.88 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DMAPKAPK2
SCHEMBL826115 0.86 GRM4 (0.39) PDE4APDE4BPDE4CPDE4DMAPKAPK2
SCHEMBL826241 0.84 TLR8 (0.43) PDE4APDE4BPDE4CPDE4DCCNB2
SCHEMBL825989 0.83 GHSR (0.41) PDE4APDE4BPDE4CPDE4DRARB
SCHEMBL823644 0.82 NPC1 (0.42) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4521670 0.82 MEN1 (0.44) PDE4APDE4BPDE4CPDE4DMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US claimed
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS PNPO, DPYD, PLPBP PDE4A 1300/4885PDE4B 1595/4885PDE4C 1685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.